Live Chat

AbbVie live chart

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Mga pinakabagong balita

Frances Wang 2024 Dec 17, 16:00

Nikkei 225 performance today: Beginner’s guide to Japan’s stock market

Indices Stocks
Frances Wang 2024 Dec 16, 16:00

MicroStrategy Stock Price: MSTR stock saw an increase of 0.15% today

Stocks
Frances Wang 2024 Dec 16, 16:00

Gold price today: gold holds two-day decline ahead of Fed rate cut

Commodities Gold
Frances Wang 2024 Dec 16, 16:00

Latest cryptocurrency news: What is bitcoin, Ethereum explained

Cryptocurrencies
Frances Wang 2024 Dec 15, 16:00

Broadcom stock price soars 23% as AI revenues spike 220%

Stocks
Dyogenes Diniz 2024 Dec 15, 16:00

Morning Note: Tesla Hits Record High Amid US PMI Focus and Bitcoin's Next Move

Cryptocurrencies US500 EUR USD
US interest rate and Europe inflation to guide market direction
Dyogenes Diniz 2024 Dec 13, 22:00

Week ahead: US Interest rate and Inflation in Europe to determine Markets Direction - Crucial Week

Forex Indices
Frances Wang 2024 Dec 12, 16:00

Elon Musk Net Worth Over $400 Billion as Tesla Stock Hits New Highs

TSLA

Info

Spread

1.12

Spread (%)

0.6400 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Miyerkules

14:31 - 20:59

Lunes

14:31-20:59

Martes

14:31-20:59

Huwebes

14:31-20:59

Biyernes

14:31-20:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

303294251008

Natitirang Pagbabahagi

1767139968

Petsa ng Mga Kita (Susunod)

0000-00-00

Pambayad si dividend

2025-02-14

Araw ng Pag-alis ng Karapatan sa Dividend

2025-01-15

Inaasahang Taunang Rate ng Dividend

6.56

Inaasahang Taunang Dividend Yield

0.0382

EPS

2.87

Alamin ang Higit Pa Tungkol sa Instrumentong ito

AbbVie AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Mga kaugnay na instrumento

view_all_instruments
Trustpilot
Live Chat